BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.42B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.87B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$704M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$517M |
| 5 |
Nike
NKE
|
+$489M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$301M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$283M |
| 3 |
State Street SPDR S&P Retail ETF
XRT
|
+$156M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$72M |
| 5 |
NVIDIA
NVDA
|
+$68.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.15% |
| 2 | Consumer Discretionary | 6.92% |
| 3 | Financials | 5.66% |
| 4 | Healthcare | 5.15% |
| 5 | Industrials | 3.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Prothena Corp
PRTA
$466M
| $112K | ﹤0.01% |
3,073
-5,252
| -63% | -$189K |
|
3152
Rimini Street
RMNI
$470M
| $112K | ﹤0.01% |
19,309
+112
| +0.6% | +$588 |
|
3153
Orion
OEC
$360M
| $112K | ﹤0.01% |
7,007
-5,938
| -46% | -$102K |
|
|
DHIL
3154
DELISTED
Diamond Hill
DHIL
| $112K | ﹤0.01% |
597
-805
| -57% | -$149K |
|
3155
PUT
ServiceNow
NOW
$132B
| $111K | ﹤0.01% |
10
-745
| -99% | -$83.5K |
|
|
AERI
3156
DELISTED
Aerie Pharmaceuticals
AERI
| $110K | ﹤0.01% |
12,123
+3,131
| +35% | +$24.1K |
|
3157
Toyota
TM
$223B
| $110K | ﹤0.01% |
611
-1,116
| -65% | -$209K |
|
|
REVG
3158
DELISTED
REV Group
REVG
| $110K | ﹤0.01% |
8,200
-4,052
| -33% | -$55.3K |
|
|
GHL
3159
DELISTED
Greenhill & Co., Inc.
GHL
| $110K | ﹤0.01% |
7,099
-225
| -3% | -$3.94K |
|
3160
Construction Partners
ROAD
$6.73B
| $109K | ﹤0.01% |
4,159
-2,199
| -35% | -$58K |
|
3161
MBIA
MBI
$262M
| $109K | ﹤0.01% |
7,071
-12,980
| -65% | -$191K |
|
3162
Ecopetrol
EC
$35.4B
| $109K | ﹤0.01% |
5,847
-22,342
| -79% | -$352K |
|
|
IBDQ
3163
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $107K | ﹤0.01% |
+4,250
| New | +$110K |
|
3164
Enel Chile
ENIC
$6.1B
| $107K | ﹤0.01% |
67,602
-23,679
| -26% | -$42.4K |
|
3165
Uranium Energy
UEC
$5.54B
| $107K | ﹤0.01% |
23,251
-38,334
| -62% | -$141K |
|
3166
Star Bulk Carriers
SBLK
$3.21B
| $106K | ﹤0.01% |
3,585
+3,583
| +179,150% | +$93.7K |
|
3167
UBS Group
UBS
$176B
| $106K | ﹤0.01% |
5,431
+3,833
| +240% | +$72.5K |
|
|
LTRPA
3168
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $106K | ﹤0.01% |
51,568
+10,697
| +26% | +$22.7K |
|
|
IDEX
3169
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $106K | ﹤0.01% |
754
-788
| -51% | -$101K |
|
|
ORC
3170
Orchid Island Capital
ORC
$1.32B
| $105K | ﹤0.01% |
6,487
-6,369
| -50% | -$120K |
|
|
ALBO
3171
DELISTED
Albireo Pharma Inc
ALBO
| $105K | ﹤0.01% |
3,505
-2,096
| -37% | -$61.4K |
|
|
BSCP
3172
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
| $104K | ﹤0.01% |
+4,985
| New | +$106K |
|
|
AMNB
3173
DELISTED
American National Bankshares Inc
AMNB
| $104K | ﹤0.01% |
2,753
-2,140
| -44% | -$81.6K |
|
3174
XBiotech
XBIT
$71M
| $103K | ﹤0.01% |
11,904
-1,115
| -9% | -$11.2K |
|
3175
PennantPark Floating Rate Capital
PFLT
$752M
| $102K | ﹤0.01% |
+7,556
| New | +$98.8K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2022 Portfolio in Review
As of Q1 2022, BNP Paribas Financial Markets held 4,480 positions worth $74.4B, up 5.9% from $70.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $8.44B of net new capital in Q1 2022, opening 238 new positions and adding to 1,135 existing holdings. Its largest new stake was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $283M trimmed.
- BNP Paribas Financial Markets's largest Q1 2022 buy was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2022, an estimated $2.42B increase.
- BNP Paribas Financial Markets's biggest Q1 2022 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $283M.
- BNP Paribas Financial Markets fully exited Xilinx Inc in Q1 2022, selling an estimated $301M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $74.4B portfolio in Q1 2022.
- BNP Paribas Financial Markets opened 238 new positions and closed 335 in Q1 2022.
- BNP Paribas Financial Markets's portfolio value rose 5.9% quarter-over-quarter to $74.4B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2022, filed 17 May 2022.